Pro-Lab Diagnostics has developed a new enzyme immunoassay (EIA) for the qualitative detection of Cryptosporidium and Giardia lamblia antigens in human faecal specimens from patients displaying gastrointestinal symptoms.
The Prolisa Cryptosporidium/Giardia EIA kit offers precise results with high sensitivity and specificity, enabling accurate diagnosis of infection.
Cryptosporidiosis is routinely diagnosed by microscopic analysis of stool samples using organic dyes or by immunostaining by direct fluorescent antibody, and can be difficult to detect. Similarly, Giardia infection is frequently misdiagnosed, relying on poorly-performing antigen-based testing.
Supplied in a 96-well test size consisting of detachable stripwekks, Prolisa Cryptosporidium/Giardia EIA uses monoclonal anti-Cryptosporidium and anti- G. lamblia antibodies to ensure sensitivity and specificity for high-value diagnostic results, and can also be performed on most automated platforms for increased workflow flexibility.
Mark Reed, general manager of Pro-Lab Diagnostics, said: “The launch of the EIA further extends the Prolisa product range, offering our customers a simple and cost-effective alternative means of testing for Cryptosporidiosis and Giardiasis .
